drugset / Trial / NCT02658721

Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery

NCT02658721

Phase 3 Completed 60 enrolled Bagcilar Training and Research Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Intravenous regional anesthesia (IVRA) is used in outpatient hand surgery as an easily applicable and cost-effective technique with clinical advantages. Nevertheless, IVRA has some disadvantages including anesthetic toxicity, slow-onset, poor muscle relaxation, tourniquet pain, and minimal postoperative pain relief. Providing an ideal anesthesia by overcoming these disadvantages is possible with the addition of some adjunct agents into local anesthetic substances. One of these adjunct agents used for IVRA is tramadol, a synthetic analgesic having opioid and nonopioid characteristics. The present study aimed to investigate the effects of addition of systemic tramadol or adjunct tramadol to lidocaine for IVRA in patients undergoing hand surgery..

Timeline

Start
2013-01
Primary completion
2013-06
Completion
2013-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 50 mg Intravenous
Background Atropine Other / unclassified 0.01 mg/kg Intramuscular
Background Atropine Other / unclassified 0.5 mg Intramuscular
Background Diclofenac Other / unclassified 75 mg Intramuscular
Background Ephedrine Small molecule 5 mg Intravenous
Background Fentanyl Other / unclassified 1 ug/kg
Comparator Lidocaine Other / unclassified 3 mg/kg Intravenous
Background Midazolam Small molecule 0.07 mg/kg Intramuscular
Background Ondansetron Other / unclassified 4 mg Intravenous

Indications

No indication recorded.